CIK 0001787306
- Large accelerated filer
Arcutis Biotherapeutics, Inc.
Sign in to watch- Ticker
- ARQT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812974255
- Phone
- +1 805-418-5006
- Business address
- 3027 TOWNSGATE ROAD, SUITE 300, WESTLAKE VILLAGE, CA, 91361
- Former names
- Arcutis, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,253,826
- in 9 filings, $2.1M under 10b5-1 plans
Net −$3,253,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-09-02 | Krishnamohan Neha Director | Grant or award · Stock Option (Right to Buy) | +29,482 | 29,482 | ||
| 2022-08-18 | Burnett Patrick | Grant or award 10b5-1 | +16,750 | 97,401 | ||
| 2022-08-15 | Welgus Howard G. Director | Sale | −6,000 | $24.80 | $149K | 174,208 |
| 2022-08-05 | Watanabe Todd Franklin President and CEO | Exercise or conversion | +2,500 | $1.68 | $4K | 654,371 |
| 2022-08-05 | Watanabe Todd Franklin President and CEO | Sale | −2,500 | $24.74 | $62K | 651,871 |
| 2022-08-05 | Watanabe Todd Franklin President and CEO | Exercise or conversion · Stock Option (Right to Buy) | −2,500 | 109,348 | ||
| 2022-08-05 | Frazier Life Sciences VIII, L.P. 10% owner | Purchase | +250,000 | $20.00 | $5.0M | 8,684,232 |
| 2022-07-18 | Welgus Howard G. Director | Sale | −6,000 | $24.40 | $146K | 180,208 |
| 2022-07-08 | OSBORNE DAVID W Chief Technical Officer | Sale | −2,197 | $25.41 | $56K | 256,649 |
| 2022-07-08 | Watanabe Todd Franklin President and CEO | Sale | −1,500 | $25.00 | $38K | 656,784 |
| 2022-07-08 | Watanabe Todd Franklin President and CEO | Sale | −4,913 | $25.41 | $125K | 651,871 |
| 2022-07-08 | Watanabe Todd Franklin President and CEO | Exercise or conversion | +7,087 | $1.68 | $12K | 658,958 |
| 2022-07-08 | Watanabe Todd Franklin President and CEO | Sale | −7,087 | $25.41 | $180K | 651,871 |
| 2022-07-08 | Watanabe Todd Franklin President and CEO | Exercise or conversion · Stock Option (Right to Buy) | −7,087 | 111,848 | ||
| 2022-07-06 | Watanabe Todd Franklin President and CEO | Sale | −1,000 | $22.07 | $22K | 658,284 |
| 2022-06-24 | ORBIMED ADVISORS LLC 10% owner | Sale | −306,027 | $21.31 | $6.5M | 3,534,537 |
| 2022-06-24 | ORBIMED ADVISORS LLC 10% owner | Sale | −35,944 | $21.31 | $766K | 415,142 |
| 2022-06-23 | Watanabe Todd Franklin President and CEO | Gift | −268,964 | 382,907 | ||
| 2022-06-06 | Watanabe Todd Franklin President and CEO | Sale | −1,000 | $21.06 | $21K | 659,284 |
| 2022-06-02 | Matsuda Masaru SVP and General Counsel | Sale | −1,795 | $19.73 | $35K | 16,380 |
Page 28 of 35 · 689 trades